Cytek Biosciences, Inc. (CTKB)
4.835
+0.04
(+0.73%)
USD |
NASDAQ |
Dec 19, 09:40
Cytek Biosciences Total Liabilities (Quarterly): 116.35M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Standard BioTools, Inc. | 139.98M |
| LENSAR, Inc. | 82.33M |
| Intelligent Bio Solutions, Inc. | 6.611M |
| Adagio Medical Holdings, Inc. | 32.86M |
| Movano, Inc. | 7.258M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 494.92M |
| Shareholders Equity (Quarterly) | 378.57M |
| Debt to Equity Ratio | 0.0929 |
| Current Ratio | 5.166 |
| Net Debt Paydown Yield | -0.09% |